COVID-19 is a leading cause of death in children and young people in the United States
COVID-19 was the underlying cause of death for more than 940,000 people in the US, including over 1,300 deaths among…
COVID-19 was the underlying cause of death for more than 940,000 people in the US, including over 1,300 deaths among…
A booster (third) dose of a SARS-CoV-2 vaccine was associated with a 90% reduction in death in people with multiple…
The antiviral drug nirmatrelvir plus ritonavir (Paxlovid) was granted Emergency Use Authorization for treating COVID-19 in December 2021. In clinical…
Many people are experiencing a variety of long COVID-19 symptoms and are relying on some of their own methods to…
The COVID-19 pandemic, caused by the SARS CoV-2 virus, continues to threaten populations around the world, after killing over 1…
Study in California Prisons Found Recent Vaccination and Boosters Reduce Infectiousness, but Infection Risk Remains High Vaccination and boosting, especially…
Molnupiravir (taken as an 800mg dose twice daily for five days) does not reduce hospital admissions or deaths in vaccinated…
The reason some people fail to recover their sense of smell after COVID-19 is linked to an ongoing immune assault…
A rehabilitation programme that helps people with long COVID reduce their symptoms and increase activity levels has shown “impressive” results, say…
In one of the first large, real-world studies comparing the effectiveness of COVID-19 vaccines versus natural immunity in protecting against…
The ongoing COVID-19 pandemic, caused by the SARS-CoV-2 virus, has been devastating the entire world. While the vaccination program is…
Those who reported having COVID in early 2020 were also 1.67 times more likely to display clinically meaningful levels of…
Researchers at Mass Eye and Ear and Northeastern University have discovered a previously unidentified immune response inside the nose that…
The Children and young people with Long Covid (CLoCk) study, published in The Lancet Regional Health – Europe, is the…
Long COVID patients can experience many of the same lingering negative effects on their physical, mental, and social well-being as…
Adults with asthma had, at one point, an approximately doubled risk of a severe asthma attack after Covid-19 restrictions were…
In a study executed by UMC Utrecht it was demonstrated that after prednisolone does not improve sense of smell after…
Following COVID-19 infection, there is significant new onset morbidity in children, adolescents and adults across 13 distinct diagnosis and symptom…
Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19…
People living in the United States are more than three times more likely to share misinformation and conspiracy theories about…
New research has revealed elevated risks of death during the COVID-19 pandemic for both COVID-19–positive and other patients on hemodialysis…
After the second and third vaccinations against COVID-19, a significantly higher antibody concentration has been confirmed, while tolerability was good….
SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug…
SARS-CoV-2 continues to circulate among us. Although some governments have moved on, a new study published today in the journal…
A comprehensive review and meta-analysis of published research confirm that young adults (40 years old and younger) have a slightly…
Belief that the COVID-19 pandemic was a hoax – that its severity was exaggerated or that the virus was deliberately…
Commonly used cholesterol-lowering statins may reduce the risk of death and severity of COVID-19 disease, suggests a study of more…
A healthy diet and avoiding the news helped prevent anxiety and depression during COVID, even better than interacting with friends,…
The risk of developing myocarditis — or inflammation of the heart muscle — is seven times higher with a COVID-19…
We’ve heard about brain fog, fatigue and headache as symptoms of long COVID. Now a new study points to another…